 |
 |
|
2 July 2002 | Volume 137 Issue 1 | Pages 56-58
This statement summarizes the current recommendations of the U.S. Preventive Services Task Force (USPSTF) for chemoprevention of breast cancer. The complete USPSTF recommendation and rationale statement on this topic, including a summary of the supporting evidence, is available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (http://www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs{at}ahrq.gov). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned.
*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295). CLINICAL GUIDELINES
Chemoprevention of Breast Cancer: Recommendations and Rationale
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  H. D. Nelson, L. H. Huffman, R. Fu, and E. L. Harris Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force Ann Intern Med, September 6, 2005; 143(5): 362 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Elmore and G. Gigerenzer Benign Breast Disease -- The Risks of Communicating Risk N. Engl. J. Med., July 21, 2005; 353(3): 297 - 299. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tice, R. Miike, K. Adduci, N. L. Petrakis, E. King, and M. R. Wrensch Nipple Aspirate Fluid Cytology and the Gail Model for Breast Cancer Risk Assessment in a Screening Population Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 324 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Dunn, D. L. Wickerham, and L. G. Ford Prevention of Hormone-Related Cancers: Breast Cancer J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Ozanne and L. J. Esserman Evaluation of Breast Cancer Risk Assessment Techniques: A Cost-effectiveness Analysis Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Lewis, L. S. Kinsinger, R. P. Harris, and R. J. Schwartz Breast Cancer Risk in Primary Care: Implications for Chemoprevention Arch Intern Med, September 27, 2004; 164(17): 1897 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Vogel, J. P. Costantino, D. L. Wickerham, and W. M. Cronin National Surgical Adjuvant Breast and Bowel Project Update: Prevention Trials and Endocrine Therapy of Ductal Carcinoma in Situ Clin. Cancer Res., January 1, 2003; 9(1): 495S - 501S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lippman and W. K. Hong Cancer Prevention Science and Practice Cancer Res., September 15, 2002; 62(18): 5119 - 5125. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Ganz Breast Cancer 2002: Where Do We Stand? CA Cancer J Clin, September 1, 2002; 52(5): 253 - 255. [Full Text] [PDF]
|
|
|
|
 |
|
 Chemoprevention of Breast Cancer Journal Watch (General), July 19, 2002; 2002(719): 1 - 1. [Full Text]
|
|
|
|
|
|
A. G. Mulley Jr. and K. Sepucha Making Good Decisions about Breast Cancer Chemoprevention Ann Intern Med, July 2, 2002; 137(1): 52 - 54. [Full Text] [PDF]
|
|
Article
